Anixa Biosciences granted Korean patent allowance for breast cancer vaccine technology
Source: SeekingAlpha
2026-03-09 09:32:39 ET
More on Anixa Biosciences
- Anixa Biosciences falls on phase 1 data for breast cancer vaccine
- Seeking Alpha’s Quant Rating on Anixa Biosciences
- Historical earnings data for Anixa Biosciences
- Financial information for Anixa Biosciences
Read the full article on Seeking Alpha
For further details see:
Anixa Biosciences granted Korean patent allowance for breast cancer vaccine technology
Anixa Biosciences Inc.
NASDAQ: ANIX
ANIX Trading
-2.16% G/L:
$2.945 Last:
14,543 Volume:
$2.98 Open:
ANIX Latest News
ANIX Stock Data
$99,470,925
24,567,316
0.4%
30
N/A
Biotechnology & Life Sciences
Healthcare
US
San Jose
